Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients (Q39122199)

9 September 2017

Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients (English)

1 reference

9 September 2017

Sondes Karray-Chouayekh

1

1 reference

9 September 2017

Fatma Trifa

2

1 reference

9 September 2017

Abdelmajid Khabir

3

1 reference

9 September 2017

Nouredine Boujelbane

4

1 reference

9 September 2017

Tahia Sellami-Boudawara

5

1 reference

9 September 2017

Jamel Daoud

6

1 reference

9 September 2017

Mounir Frikha

7

1 reference

9 September 2017

Rachid Jlidi

8

1 reference

9 September 2017

Ali Gargouri

9

1 reference

9 September 2017

Raja Mokdad-Gargouri

10

1 reference

9 September 2017

language of work or name

1 reference

6 August 2009

1 reference

Journal of Cancer Research and Clinical Oncology

9 September 2017

1 reference

9 September 2017

136

1 reference

9 September 2017

203-210

1 reference

9 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-009-0649-6

9 September 2017

0 references

cites work

Correlation between CpG methylation profiles and hormone receptor status in breast cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00432-009-0649-6

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-009-0649-6

Quantitative assessment of promoter hypermethylation during breast cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-009-0649-6

Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-009-0649-6

Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients

21 January 2018

1 reference

12 December 2020

Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status

1 reference

12 December 2020

Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.

1 reference

12 December 2020

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

12 December 2020

Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma

1 reference

12 December 2020

Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers

1 reference

12 December 2020

Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers

1 reference

12 December 2020

Evidence for a role of the Simian Virus 40 in human breast carcinomas.

1 reference

12 December 2020

CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer

1 reference

12 December 2020

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

1 reference

12 December 2020

Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer

1 reference

12 December 2020

Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.

1 reference

12 December 2020

DNA methylation patterns and epigenetic memory

1 reference

12 December 2020

Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma

1 reference

12 December 2020

Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients

1 reference

12 December 2020

Hypermethylation in histologically distinct classes of breast cancer

1 reference

12 December 2020

DNA hypermethylation in breast cancer and its association with clinicopathological features.

1 reference

12 December 2020

The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis

1 reference

12 December 2020

Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.

1 reference

12 December 2020

The lifetime risk of developing breast cancer

1 reference

12 December 2020

A gene hypermethylation profile of human cancer

1 reference

12 December 2020

CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

1 reference

12 December 2020

Estrogen receptors: role in breast cancer.

1 reference

12 December 2020

DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma

1 reference

12 December 2020

A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women

1 reference

12 December 2020

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

1 reference

12 December 2020

DNA methylation and breast carcinogenesis.

1 reference

12 December 2020

Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome

1 reference

12 December 2020

Epigenetics and breast cancer

1 reference

12 December 2020

DNA methylation and breast cancer

1 reference

12 December 2020

Methylation and prognosis: of molecular clocks and hypermethylator phenotypes

1 reference

12 December 2020

Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women

1 reference

12 December 2020

Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.

1 reference

12 December 2020

Epidemiologic features of rapidly progressing breast cancer in Tunisia

1 reference

12 December 2020

Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.

1 reference

12 December 2020

Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors

1 reference

12 December 2020

Methylation of the p16(Ink4a) tumor suppressor gene 5'-CpG island in breast cancer

1 reference

12 December 2020

The fundamental role of epigenetic events in cancer

1 reference

12 December 2020

10.1007/S00432-009-0649-6

Identifiers

DOI

1 reference

9 September 2017

1 reference